Premium
Reduced immunoglobulin levels in epilepsy patients treated with levetiracetam, lamotrigine, or carbamazepine
Author(s) -
Svalheim S.,
Mushtaq U.,
Mochol M.,
Luef G.,
Rauchenzauner M.,
Frøland S. S.,
Taubøll E.
Publication year - 2013
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/ane.12044
Subject(s) - lamotrigine , levetiracetam , carbamazepine , medicine , epilepsy , immunoglobulin g , antibody , immunoglobulin m , gastroenterology , immunology , psychiatry
Objectives The aim of the study was to investigate immunoglobulin levels in patients with epilepsy using the antiepileptic drugs ( AED ) levetiracetam ( LEV ), carbamazepine ( CBZ ), or lamotrigine ( LTG ). Methods A total of 211 patients and 80 controls (age: 18–45 years) of both genders were included. The patients had been treated with either LEV (n = 47), CBZ (n = 90), or LTG (n = 74) monotherapy for at least 6 months. Total concentrations of immunoglobulin G (IgG), IgG subclasses (IgG1, IgG2, IgG3, and IgG4), immunoglobulin A (IgA), and immunoglobulin M (IgM) were measured. Smoking, drinking habits, and physical activity were recorded, and body mass index ( BMI ) was calculated. Results A significantly lower total IgG and IgG1 was found in both men and women treated with LTG and in men on CBZ . IgG2 and IgG4 were also lower in LTG ‐treated women, and IgA and IgM were lower in LTG ‐treated men. Patients treated with LEV did not differ from the control group. Conclusions Low levels of immunoglobulins were found in patients with epilepsy treated with LTG or CBZ . As our group of patients consisted of otherwise healthy young adults, one should be especially aware of a possible effect of AED s on immunoglobulin levels when treating selected patient groups, for example immunocompromised patients. Immunoglobulin concentrations should be measured in patients treated with LTG or CBZ who experience recurrent infections, and a change in medication should be considered.